title: Five years of self-administered hyaluronidase facilitated subcutaneous immunoglobulin (fSCIg) home therapy in a patient with primary immunodeficiency.
authors.affiliation: Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK.
authors.forename: Emily
authors.initials: E
authors.lastname: Carne
authors.affiliation: Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK.
authors.forename: Mark
authors.initials: M
authors.lastname: Ponsford
authors.affiliation: Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK.
authors.forename: Tariq
authors.initials: T
authors.lastname: El-Shanawany
authors.affiliation: Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK.
authors.forename: Paul
authors.initials: P
authors.lastname: Williams
authors.affiliation: Department of Neurology, University Hospital of Wales, Cardiff, UK.
authors.forename: Trevor
authors.initials: T
authors.lastname: Pickersgill
authors.affiliation: Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK.
authors.forename: Stephen
authors.initials: S
authors.lastname: Jolles
mesh_terms: D000328:Adult; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000008:administration & dosage*; D007136:Immunoglobulins / Q000008:administration & dosage*; D055104:Infusions, Subcutaneous; D012646:Self Administration; D016511:Severe Combined Immunodeficiency / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D013848:Thigh; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007136:Immunoglobulins; D006821:Hyaluronoglucosaminidase
keywords: IMMUNODEFICIENCY; IMMUNOGLOBULIN; IMMUNOLOGY